Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,205.50
-0.80 (-0.04%)
At close: Dec 5, 2025
Mankind Pharma Revenue
Mankind Pharma had revenue of 36.97B INR in the quarter ending September 30, 2025, with 20.17% growth. This brings the company's revenue in the last twelve months to 135.46B, up 22.94% year-over-year. In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B with 18.98% growth.
Revenue (ttm)
135.46B
Revenue Growth
+22.94%
P/S Ratio
6.72
Revenue / Employee
5.02M
Employees
26,978
Market Cap
910.34B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Divi's Laboratories | 100.29B |
| Cipla | 279.66B |
| Apollo Hospitals Enterprise | 232.65B |
| Zydus Lifesciences | 244.94B |
| Aurobindo Pharma | 325.14B |
| Alkem Laboratories | 138.90B |
| Fortis Healthcare | 84.37B |